Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Approval, Single-Arm Study of the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China

NCT03736226 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03736226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Approval, Single-Arm Study of the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
July 30, 2019
Completion date
March 31, 2028
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases